BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
95.03
+0.89 (0.95%)
Dec 24, 2025, 4:00 PM EST - Market closed
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $22.85 billion as of December 24, 2025. Its market cap has decreased by -21.69% in one year.
Market Cap
22.85B
Enterprise Value
5.88B
1-Year Change
-21.69%
Ranking
Category
Stock Price
$95.03
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $22.85B, an increase of 662.96%. That is a compound annual growth rate of 38.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 22.64B | -17.14% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | 19.63B | 156.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 963.86B |
| Johnson & Johnson | 499.50B |
| AbbVie | 402.80B |
| UnitedHealth Group | 294.54B |
| AstraZeneca | 284.34B |
| Novartis AG | 263.31B |
| Merck & Co. | 259.92B |
| Abbott Laboratories | 217.70B |